Lukas Ronner
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Genetics 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Hemoglobinopathies and Related Disorders 3
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Co-authors
- Clifford S. Deutschman (1 shared paper)Pratik Sinha (1 shared paper)Alexandre V. Hirayama (1 shared paper)Matthew Taylor (1 shared paper)Daniel E. Leisman (1 shared paper)Carolyn S. Calfee (1 shared paper)Cameron J. Turtle (1 shared paper)Michael O. Harhay (1 shared paper)
- Journals
- Blood (2 papers)Gynecologic Oncology (1 paper)HemaSphere (1 paper)Academic Medicine (1 paper)Journal of Neuro-Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Lukas Ronner
14 papers receiving 889 citations
Lukas Ronner's Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 323
- Neurology 173
- Oncology 261
- Immunology 156
- Critical Care and Intensive Care Medicine 33
Countries citing papers authored by Lukas Ronner
This map shows the geographic impact of Lukas Ronner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Ronner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Ronner more than expected).
Fields of papers citing papers by Lukas Ronner
This network shows the impact of papers produced by Lukas Ronner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Ronner. The network helps show where Lukas Ronner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lukas Ronner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes Hit paper breakdown → | 2020 | 565 |
| 2 | 2015 | 245 | |
| 3 | 2017 | 14 | |
| 4 | 2014 | 13 | |
| 5 | 2020 | 12 | |
| 6 | 2022 | 12 | |
| 7 | 2019 | 11 | |
| 8 | 2016 | 10 | |
| 9 | 2016 | 9 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2022 | 1 |
About Lukas Ronner
Lukas Ronner is a scholar working on Genetics, Molecular Biology, Surgery, Oncology and Epidemiology, having authored 14 papers that have together received 905 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Hemoglobinopathies and Related Disorders (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Acute Myeloid Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Head and Neck Cancer Studies (1 paper), Radiology practices and education (1 paper) and Cervical Cancer and HPV Research (1 paper). The work is most often cited by research in Infectious Diseases (323 citations), Neurology (173 citations), Oncology (261 citations), Immunology (156 citations) and Critical Care and Intensive Care Medicine (33 citations). Lukas Ronner has collaborated with scholars based in United States. Frequent co-authors include Clifford S. Deutschman, Pratik Sinha, Alexandre V. Hirayama, Matthew Taylor, Daniel E. Leisman, Carolyn S. Calfee, Cameron J. Turtle, Michael O. Harhay, Rachel Pinotti and Matthieu Legrand. Their work appears in journals such as Blood, Gynecologic Oncology, HemaSphere, Academic Medicine and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.